ARID1A GENE MUTATION
Clinical trials for ARID1A GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new ARID1A GENE MUTATION trials appear
Sign up with your email to follow new studies for ARID1A GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise against Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental oral drug called JAB-2485 in adults with advanced solid tumors, including certain breast and lung cancers. The goal is to see if the drug is safe and can shrink tumors. About 102 participants will receive the drug, and researchers will monitor sid…
Matched conditions: ARID1A GENE MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New combo targets tough endometrial cancer in small trial
Disease control Recruiting nowThis phase 2 study tests whether combining avelumab (an immunotherapy) with M1774 (a targeted drug) can shrink tumors or delay cancer growth in 25 people with ARID1A-mutated endometrial cancer that has returned after prior immunotherapy. Participants receive both drugs intravenou…
Matched conditions: ARID1A GENE MUTATION
Phase: PHASE2 • Sponsor: Panagiotis Konstantinopoulos, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC